Clinical application of growth factors and cytokines in wound healing
Tóm tắt
Wound healing is a complex and dynamic biological process that involves the coordinated efforts of multiple cell types and is executed and regulated by numerous growth factors and cytokines. There has been a drive in the past two decades to study the therapeutic effects of various growth factors in the clinical management of nonhealing wounds (e.g., pressure ulcers, chronic venous ulcers, diabetic foot ulcers). For this review, we conducted an online search of
Từ khóa
Tài liệu tham khảo
Center for Disease Control and Prevention.National diabetes fact sheet 2011. Available at:http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf(accessed February 19 2013).
Brown G, 2003, Long‐term outcomes of full thickness pressure ulcers: healing and mortality, Ostomy Wound Manage, 49, 42
Russo A, 2008, Hospitalizations related to pressure ulcers among adults 18 years and older, 2006
Yomen A, 1996, Effects of granulocyte colony stimulating factor in the treatment of diabetic foot infection, J Invest Dermatol, 107, 404
Schriber J, 1993, The efficacy of granulocyte colony‐stimulating factor following autologous bone marrow transplantation for non‐Hodgkin's lymphoma with monoclonal antibody purged bone marrow, Leukemia, 7, 1491
Visani G, 1990, Accelerated hemopoietic recovery after chemotherapy and autologous bone marrow transplantation in hematological malignancies using recombinant GM‐CSF; preliminary results obtained in14 cases, Hematologica, 75, 551
Gorin N, 1992, Recombinant human granulocyte‐macrophage colony stimulating factor after high dose chemotherapy and autologous bone marrow transplantation with unpurged and purged marrow in non‐Hodgkin's lymphoma: A double blind placebo controlled trial, Blood, 80, 1149, 10.1182/blood.V80.5.1149.1149
Bayer Pharmacuticals.Leukine 2009.http://www.pharma.bayer.com/scripts/pages/en/news_room/news_room/news_room79.php(accessed May 30 2013).
West N, 1995, Systemic antimicrobial treatment of foot infections in diabetic patients, Am J Health Syst Pharm, 52, 1199, 10.1093/ajhp/52.11.1199
Wang Z, 2008, Effect of recombinant human granulocyte‐macrophage colony stimulating factor on wound healing in patients with deep partial thickness burn, Zhonghua Shao Shang Za Zhi, 24, 107
Sundberg C, 1997, Tumor cell and connective tissue cell interaction in human colorectal adenocarcinoma. Transfer of platelet‐derived growth factor‐AB/BB to stromal cells, Am J Pathol, 151, 479
Food and Drug Administration.Regranex 2008http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM142821.pdf(accessed May 30 2013).
D'Hemecourt P, 1998, Sodium carboxymethylcellulose aquesous‐based gel vs. becapleermin gel in patients with nonhealing lower extremity diabetic ulcers, Wounds, 10, 69
Uchi H, 2009, Clinical Efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcers, Eur J Dermatol, 19, 461, 10.1684/ejd.2009.0750
Nie K, 2010, Clinical observation of basic fibroblast growth factor combined with topical oxygen therapy in enhancing burn wound healing, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, 24, 643
Guo H, 2009, Effects of perforated bovine amnion combined with recombinant bovine basic fibroblast growth factor on degree II burn wounds: a comparison with imperforated bovine amnion and Vaseline gauze dressing, J Clin Rehab Tissue Eng Res, 13, 10193
Chang F, 2009, Gene gun‐delivered human basic fibroblast growth factor gene facilitates the healing of deep partial thickness burn wounds, J Clin Rehab Tissue Eng Res, 13, 4611
Robson M, 2004, Healing of chronic venous ulcers is not enhanced by the addition of topical repifermin (KGF‐2) to standardized care, J Appl Res, 4, 302
Suzuma K, 1998, Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells, Invest Ophthalmol Vis Sci, 39, 1028
Senger D, 1996, Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanism involving the alphavbeta3 integrin, osteopontin, and thrombin, Am J Pathol, 149, 293
Morbidelli L, 1996, Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium, Am J Physiol, 270, H411
Goto F, 1993, Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels, Lab Invest, 69, 508
Nissen N, 1998, Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing, Am J Pathol, 152, 1445
Bauters C, 1994, Physiological assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb, Am J Physiol, 267, 1263
Takeshita S, 1995, Intramuscular administration of vascular endothelial growth factor induces dose‐dependent collateral artery augmentation in a rabbit model of chronic limb ischemia, Circulation, 90, 228
Steed D, 1996, Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group, J Am Coll Surg, 183, 61